Acceleron Pharma (English Wikipedia)
Analysis of information sources in references of the Wikipedia article "Acceleron Pharma" in English language version.
refsWebsite
Global rank
English rank
274th place
309th place
low place
8,828th place
low place
low place
1st place
1st place
615th place
407th place
5,641st place
4,405th place
6,813th place
5,125th place
low place
low place
3rd place
3rd place
22nd place
19th place
low place
low place
310th place
208th place
407th place
241st place
low place
6,978th place
234th place
397th place
2,737th place
1,700th place
low place
low place
acceleronpharma.com
acceleronpharma.com
- "Acceleron Management Team". Acceleron Pharma, Inc.
- "Our Pipeline". Acceleron Pharma, Inc.
investor.acceleronpharma.com
- "Acceleron Pharma, Developing Drugs to Treat Musculoskeletal and Metabolic Disorders, Secures $25 Million in Series A Funding (NASDAQ:XLRN)". investor.acceleronpharma.com. February 13, 2004. Archived from the original on February 16, 2017. Retrieved February 15, 2017.
annualreports.com
- "2017 Annual Report, Interactive Annual Report and Form 10K" (PDF). www.annualreports.com. Retrieved 6 December 2018.[permanent dead link]
barrons.com
- Nathan-Kazis, Josh (2019-09-17). "Acceleron Gives Up on Rare Genetic Disease. Analysts Are Still Bullish on the Stock". www.barrons.com. Retrieved 2019-10-21.
biocentury.com
- Flanagan, Michael (July 17, 2006). "Acceleron: Value in the wallflower". Biocentury.
biopharmadive.com
- "Merck cardiovascular drug succeeds in study, validating $11B buyout bet". BioPharma Dive. Retrieved 2022-10-11.
bizjournals.com
- "Acceleron's Celgene deal worth almost $2B". Boston Business Journal. February 20, 2008.
books.google.com
- Cooke, Philip, ed. (2007). "Local clusters and global networks". Regional Knowledge Economies (Google eBook). New horizons in regional science. United Kingdom: Edward Elgar Publishing. p. 79. ISBN 9781847206930.
boston.com
archive.boston.com
- Heuser, Stephen (July 16, 2007). "Super-buff cattle may hold key to treating muscular diseases". Boston Globe.
businesswire.com
- "Press Release: Acceleron Pharma Appoints Glenn Batchelder as CEO and Adds Richard F. Pops to Board of Directors". Acceleron via Businesswire. June 14, 2004.
- "Merck to Acquire Acceleron Pharma Inc". Businesswire. 30 September 2021.
fiercebiotech.com
- "Press Release: Acceleron Pharma Announces Departure of Jasbir Seehra, Ph.D. Chief Scientific Officer". Acceleron via FierceBiotech. November 24, 2010.
- Carroll, John (November 1, 2007). "Emerging Drug Developer: Acceleron". FierceBiotech.
- "Celgene commits $1.9B to Acceleron". FierceBiotech. February 20, 2008.
- Lawrence, Stacy (September 28, 2016). "Bayer commercial vet heads to Acceleron as it preps for PhIII Celgene data". FierceBiotech.
latimes.com
- McLellan, Dennis (January 18, 2012). "Wylie W. Vale Jr. dies at 70; researcher helped discover stress hormone". Los Angeles Times.
lifescienceleader.com
- "What Are Some Of The Most Interesting Insights Gained From Serving On A Corporate Board That Have Made You A Better Leader?". Life Science Leader. VertMarkets. September 8, 2017. Retrieved September 28, 2017.
Francois is chairman of the board at Acceleron Pharma.
macrotrends.net
- "Acceleron Pharma Revenue 2012-2021 | XLRN". Archived from the original on 2021-08-14. Retrieved 2020-10-11.
nature.com
- Huggett, Brady (December 2013). "Burning Bright". Nature Biotechnology. Vol. 31, no. 12. pp. 1068–71.
sec.gov
- "Acceleron S-1". Acceleron via SEC Edgar. August 7, 2013.
springer.com
adisinsight.springer.com
- "Luspatercept". AdisInsight. Retrieved 15 February 2017.
- "Sotatercept". AdisInsight. Retrieved 15 February 2017.
- "Dalantercept". AdisInsight. Retrieved 15 February 2017.
- "ACE 083". AdisInsight. Retrieved 15 February 2017.
web.archive.org
- "Acceleron Pharma Revenue 2012-2021 | XLRN". Archived from the original on 2021-08-14. Retrieved 2020-10-11.
- "Acceleron Pharma, Developing Drugs to Treat Musculoskeletal and Metabolic Disorders, Secures $25 Million in Series A Funding (NASDAQ:XLRN)". investor.acceleronpharma.com. February 13, 2004. Archived from the original on February 16, 2017. Retrieved February 15, 2017.
xconomy.com
- Weintraub, Arlene (3 August 2011). "Acceleron Gets $25 Million in Partnership Deal With Celgene". Xconomy.
yahoo.com
finance.yahoo.com
- "Merck Completes Acquisition of Acceleron Pharma Inc". BusinessWire. November 22, 2021 – via Yahoo! Finance.